About Amster Microcell
Amster Microcell is a Healthcare company based in India founded in 2018. It produces excipients like microcrystalline cellulose for pharmaceutical and nutraceutical industries. It operates on a B2B model. The company has 24 employees. Its Indian entity Amster Microcell Private Limited reported revenue of ₹55.81 Cr. Amster Microcell offers products and services including Microcrystalline cellulose, Magnesium stearate, Croscarmellose sodium, and Sodium starch glycollate. Its focus areas include Nutraceuticals, Ingredients, Excipient Production and Pharmaceuticals.
Company details
Amster Microcell specializes in manufacturing high-quality excipients such as microcrystalline cellulose, magnesium stearate, and croscarmellose sodium for pharmaceutical applications. Based in Gujarat, India, they use advanced technology to ensure precision and reliability in production. The company serves global pharmaceutical companies, focusing on sustainable practices and quality certifications to meet industry standards, while expanding facilities for better outcomes.
- Headquarters India
- Employees 24
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website amstermicrocell.com
- Social LinkedIn Facebook Instagram
- Legal Name Amster Microcell Private Limited
- Date of Incorporation 06 Mar, 2018
- Jurisdiction Kadi, Gujarat, India
- Annual Revenue₹55.81 Cr
FY 2025 · +50% YoY
- Net Profit₹4.64 Cr
FY 2025 · 8% margin
- EBITDA₹7.79 Cr
FY 2025 · 14% margin
- Employee Count24
Associated legal entities of Amster Microcell
Amster Microcell operates through Amster Microcell Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Amster Microcell Private Limited CIN U24304GJ2018PTC101080 | Active | 06 Mar 2018 | Kadi, Gujarat | ₹55.8 Cr | 24 | 6 | View details |
Products & Services of Amster Microcell
Amster Microcell offers a comprehensive portfolio of products and services, including Microcrystalline cellulose, Magnesium stearate, Croscarmellose sodium, and Sodium starch glycollate.
Powder used for direct compression in pharmaceutical formulations
Lubricant enhancing tablet flow and compression properties
Disintegrant for improved drug dissolution in tablets
Binder and disintegrant in pharmaceutical manufacturing processes
Board of directors of Amster Microcell Private Limited (Amster Microcell)
Amster Microcell Private Limited is the primary company behind Amster Microcell. The board of Amster Microcell Private Limited currently have 6 directors; the longest-serving is Dilipkumar Hanvantraj Gulechha, appointed in 2018. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Dilipkumar Hanvantraj Gulechha DIN 06696344 | Director | 06 Mar 2018 | 8 yrs 7 mo | Amster Microcell Private Limited |
| Vijay Ganpatbhai Patel DIN 07981519 | Director | 06 Mar 2018 | 8 yrs 7 mo | Amster Microcell Private Limited |
| Sureshbhai Mithalal Mehta DIN 01488210 | Director | 24 Jul 2018 | 8 yrs 3 mo | Amster Microcell Private Limited |
| Niraj Sureshbhai Mehta DIN 08821789 | Director | 19 Aug 2021 | 5 yrs 2 mo | Amster Microcell Private Limited |
| Harsh Gulechha DIN 09286492 | Director | 19 Aug 2021 | 5 yrs 2 mo | Amster Microcell Private Limited |
| Manoj Hanwantraj Gulechha DIN 09456507 | Director | 27 Mar 2023 | 3 yrs 7 mo | Amster Microcell Private Limited |
Financials of Amster Microcell
Figures of Amster Microcell Private Limited, the primary company behind Amster Microcell, for FY 2025. Revenue was ₹55.81 Cr (+50% year on year). Net profit was ₹4.64 Cr (8% margin). EBITDA was ₹7.79 Cr (14% margin). Revenue has grown at a compounded annual rate of +24% over three years and +379% over five years.
- ₹55.81 CrRevenue · FY 2025 · +50% YoY
- ₹4.64 CrNet profit · 8% margin
- ₹7.79 CrEBITDA · 14% margin
- ₹10,000Paid-up capital
- 24Employees (provident fund records)
- +24%Revenue CAGR, 3 years
- +379%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Amster Microcell Private Limited are on its company page.
Detailed financial statements for Amster Microcell
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as Amster Microcell (Nutraceutical & Food-as-Medicine Platforms) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | 2016 | Bengaluru, Karnataka, India | USD 77.85 M | USD 27.35 M | 362 | |
Nutritional supplements for multiple health ailments are developed. | 2005 | Mumbai, Maharashtra, India | USD 1.55 M | |||
Nutritional food and health supplements are provided by OZiva. | 2010 | Mumbai, Maharashtra, India | USD 17.32 M | USD 23.98 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Amster Microcell
Amster Microcell was founded in 2018.
Amster Microcell is headquartered in India.
Amster Microcell has 24 employees.
The primary company behind Amster Microcell, Amster Microcell Private Limited, reported revenue of ₹55.81 Cr for FY 2025, up 50% year on year.
Amster Microcell specializes in manufacturing high-quality excipients such as microcrystalline cellulose, magnesium stearate, and croscarmellose sodium for pharmaceutical applications. Based in Gujarat, India, they use advanced technology to ensure precision and reliability in production. The company serves global pharmaceutical companies, focusing on sustainable practices and quality certifications to meet industry standards, while expanding facilities for better outcomes.
Amster Microcell offers Microcrystalline cellulose, Magnesium stearate, Croscarmellose sodium, and Sodium starch glycollate.
Amster Microcell operates through Amster Microcell Private Limited.
The legal entities of Amster Microcell currently have 6 directors, including Dilipkumar Hanvantraj Gulechha, Vijay Ganpatbhai Patel, Niraj Sureshbhai Mehta and others.